<img alt="" height="1" width="1" />Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDANews-Medical.netThe purpose of the meeting was to discuss the completion of the Company's non-C IBS Development Program, the results of two Phase 3 trials, ...<nobr></nobr> |